Lab testing chain Adicon joins IPO rush as Covid cash dwindles
One of China’s biggest independent laboratory operators is trying to jump on the Hong Kong IPO bandwagon before its Covid testing revenues tumble Key takeaways: Adicon’s Covid test services powered…
Recent Articles
RELATED ARTICLES
-
As Covid drug cash dwindles, Vigonvita targets new remedies
- Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
-
Bumper dividend could trigger buyout for Ping An Health
1833.HK
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
- IPO pitch puts BrainAurora’s earnings under the microscope
- Huoli rides China travel boom to Hong Kong IPO
- Tianyu Semiconductor seeks IPO cash infusion in turbulent market
